Remedium Lifecare gets nod to merge MVK Lifesciences with itself

15 Nov 2022 Evaluate

Remedium Lifecare’s board of directors has approved the Memorandum of Understanding (MoU) for the proposed merger of MVK Lifesciences (MVK) into the Company for strategic reasons. The proposed merger would be in the best interest of the Parties and their respective shareholders, employees, creditors and other stakeholders as the proposed merger will yield advantages i.e. pooling of resources, achieving economies of scale creating better synergies and long-term sustainability of the business, backward integration of manufacturing facility leading to overall growth of business, create value for stakeholders including respective shareholders, customers, lenders and employees as the combined business would benefit from increased scale, innovations in technology and expanded reach with increased growth opportunities, higher cross selling opportunities to a larger base of customers, improvement in productivity and operational efficiencies, amongst others and greater ability of the company to raise financial resources, either as equity or debt, based on combined financials.  The Board of Directors at its meeting held on November 14, 2022 has approved the same.

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.

Remedium Lifecare Share Price

1.79 0.03 (1.70%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 245.50
Adani Enterprises 2351.30
Amrapali Industries 17.33
Rashi Peripheral 294.25
Prithvi Exchange (I) 167.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...